Ketamine One (NEO:MEDI.AQN) Interim CEO Adam Deffett joined Steve Darling from Proactive to share news the company has announced that it has established a Medical Advisory Board to help guide the development of Ketamine One’s mental health platform. That board will be Chaired by Ketamine One’s Chief Medical Officer, Dr. Mark Kimmins.
Deffett also told Proactive, the company's subsidiary, Integrated Rehab and Performance has rebranded to IRP Health and is expanding its business through the addition of four new, veteran-focused clinics in the Comox Valley and in Ottawa, Halifax and Surrey, BC.
Deffett also shared with Proactive the company has announced that it has reached a commercial agreement with Cognetivity Neurosciences for Cognetivity’s Integrated Cognitive Assessment to be used in Ketamine One’s clinics across North America.